Plus Therapeutics-marc Hedrick-benzinga All Access
- last year
Plus Therapeutics is a clinical-stage pharmaceutical company developing targeted radiotherapeutics for difficult-to-treat cancers of the central nervous system. The company’s technology combines image-guided local beta radiation and targeted drug delivery approaches to treat recurrent glioblastoma (GBM) and leptomeningeal metastases (LM).
Recommended
"La vapoteuse remboursée ? Bientôt des cancers à la framboise et des métastases au Nutella"
replay tv
Full version The Metastases of Enjoyment: On Women and Casuality: On Women and Causality
brodietalynn